Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with Type 2 diabetes for at least 12 months
- You have been taking a certain type of diabetes medication (called an SGLT2 inhibitor and/or GLP-1 receptor agonist) for at least 3 months, or these medications have been offered to you in the past (confirm with trial site)
- You have been using insulin to manage your diabetes for at least 6 months
- Your recent blood sugar control result (called HbA1c) is at or below a certain level, measured by a local lab (confirm with trial site)
- You are willing to wear study devices and follow the instructions given during the study
- You are able to understand the study and give your own consent to take part
Who may not be able to join:
- You have Type 1 diabetes
- You currently use an insulin pump
- You currently use any automated closed-loop insulin delivery system (sometimes called an "artificial pancreas") (confirm with trial site)
- You have a physical or mental health condition, or take medications, that the study doctor thinks could affect the study results
- You have a known or suspected allergy to insulin
- You have a documented allergy to adhesive materials (like the glue used in plasters or patches)
- You are pregnant, planning to become pregnant, or currently breastfeeding
- You have severe visual impairment
- You have severe hearing impairment
- You have a serious skin condition in areas of the body where the glucose sensor may need to be placed
- You currently misuse illicit (illegal) drugs
- You currently misuse prescription medications
- You currently misuse alcohol
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Roman Hovorka, University of Cambridge
Phone: +44 (0)1223 769066
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Glycated haemoglobin (HbA1c) at 26 weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.